Advanced search

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

(2013) JOURNAL OF CROHNS & COLITIS. 7(2). p.154-160
Author
Organization
Keywords
Adalimumab, Dose escalation, Dose de-escalation, Crohn's disease, DISEASE, INFLIXIMAB, THERAPY, EXPERIENCE, TRIAL

Citation

Please use this url to cite or link to this publication:

Chicago
Baert, Filip, Elien Glorieus, Cathérine Reenaers, Geert D’Haens, Harald Peeters, Dennis Franchimont, Olivier Dewit, Philippe Caenepeel, Edouard Louis, and Gert Van Assche. 2013. “Adalimumab Dose Escalation and Dose De-escalation Success Rate and Predictors in a Large National Cohort of Crohn’s Patients.” Journal of Crohns & Colitis 7 (2): 154–160.
APA
Baert, Filip, Glorieus, E., Reenaers, C., D’Haens, G., Peeters, H., Franchimont, D., Dewit, O., et al. (2013). Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn’s patients. JOURNAL OF CROHNS & COLITIS, 7(2), 154–160.
Vancouver
1.
Baert F, Glorieus E, Reenaers C, D’Haens G, Peeters H, Franchimont D, et al. Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn’s patients. JOURNAL OF CROHNS & COLITIS. 2013;7(2):154–60.
MLA
Baert, Filip, Elien Glorieus, Cathérine Reenaers, et al. “Adalimumab Dose Escalation and Dose De-escalation Success Rate and Predictors in a Large National Cohort of Crohn’s Patients.” JOURNAL OF CROHNS & COLITIS 7.2 (2013): 154–160. Print.
@article{8552389,
  author       = {Baert, Filip and Glorieus, Elien and Reenaers, Cath{\'e}rine and D'Haens, Geert and Peeters, Harald and Franchimont, Dennis and Dewit, Olivier and Caenepeel, Philippe and Louis, Edouard and Van Assche, Gert},
  issn         = {1873-9946},
  journal      = {JOURNAL OF CROHNS \& COLITIS},
  keyword      = {Adalimumab,Dose escalation,Dose de-escalation,Crohn's disease,DISEASE,INFLIXIMAB,THERAPY,EXPERIENCE,TRIAL},
  language     = {eng},
  number       = {2},
  pages        = {154--160},
  title        = {Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients},
  url          = {http://dx.doi.org/10.1016/j.crohns.2012.03.018},
  volume       = {7},
  year         = {2013},
}

Altmetric
View in Altmetric
Web of Science
Times cited: